BISU News SAN ANTONIO, July 30, 2012 /PRNewswire/ --

New Post Public Reply Private Reply Replies (0) Message Board
chuck44l
BISU News


SAN ANTONIO, July 30, 2012 /PRNewswire/ -- (BISU) (BISU) Bio-Solutions Corp is pleased to announce that the company has started production of the recently acquired Type2 Defense™. Type2 Defense™ is an Antioxidant and glucose control dietary supplement powder. This proprietary formula is packaged with 30 packets to a box. The product powder drink mix delivery system has been developed to support healthy glucose levels for type 2 diabetics and pre-diabetics. From a "Target Market" perspective, management believes this to be a very lucrative market place that has a built in clientele here domestically in North America to drive sales and revenues. Type2 Defense™ has been scheduled for Market entry by September 2012. "We will be completing the first production run of Type2 Defense™ very soon. We are excited about our new product, which will be sold and marketed primarily on the internet, further company developments, forthcoming," stated newly appointed CEO Bill Gallagher.

There is an Estimated 100 plus Million Americans at risk of diabetes in the following order: Data from the 2011 National Diabetes Fact Sheet (released Jan. 26, 2011) Total prevalence of diabetes Total: 25.8 million children and adults in the United States -- 8.3% of the population -- have diabetes. Diagnosed: 18.8 million people Undiagnosed: 7.0 million people Pre-diabetes: 79 million people

New Cases: 1.9 million new cases of diabetes are diagnosed in people aged 20 years and older in 2010.

In contrast to the 2007 National Diabetes Fact Sheet, which used fasting glucose data to estimate undiagnosed diabetes and pre-diabetes, the 2011 National Diabetes Fact Sheet uses both fasting glucose and A1C levels to derive estimates for undiagnosed diabetes and pre-diabetes. These tests were chosen because they are most frequently used in clinical practice.

Given the two types of Diabetes (Type 1 and Type 2), Type2 Defense(TM) will obviously cater to Type 2 patients, which are 90-95%, of all diabetics. Type2 Defense(TM) will help maintain healthy blood glucose levels to combat complications of Diabetes which include: high blood
pressure

Operations will be managed in San Antonio. Research and development is managed by Ex Nestles SA nutritional food chief scientist Sekhar Mallangi. Product fulfillment will be handled by Lou Bellino, one of Americas top web product fulfillment operators, marketing will be driven by the talented San Antonio based marketing firm BOSS Creative for the company's new upcoming website development. Search engine optimization (SEO) management, video product description and newsletters.

According to Dailyfinance.com (1/27/11 Big Pharma Article), "In 2009, the U.S. diabetes market grew 17% from 2008, reaching $14.9 billion, according to data from health care information company IMS Health. Worldwide, the market generated sales of over $25 Billion, according to independent business information provider Vision again. By 2019, Morningstar projects the worldwide diabetes market, excluding insulin, will grow to over $55 billion."

We believe that there is a growing market place that lacks adequate healthy tools to maintain healthy blood glucose levels. Type2 Defense(TM) is a powder blend of natural ingredients that has been developed to help support healthy blood glucose levels. The Type2 Defense(TM) powder blend is a flavorful supplement when mixed with water becomes an effective vehicle that encourages sustainable healthy habits. A convenient and all natural pure health beverage containing green tea blended with cinnamon and blueberry flavors and the Type2 Defense(TM) proprietary blend. The Product's goal is to provide a safe and natural supplement that will assist in the stabilization of healthy glucose levels along with providing strong antioxidants.

Forward-Looking Statements

This press release contains forward-looking statements made pursuant to the safe harbor provisions of the U.S. Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties, which could cause the Bio-Solutions actual results to differ materially from those in the forward-looking statements. Investors are cautioned not to rely on these forward-looking statements. The Company does not undertake to update these forward-looking statements and disclaims any obligation to update any such factors or to publicly announce the result of any revisions to any of the forward-looking statements contained herein to reflect future results, events or developments, except if we are requested by a governmental authority or applicable law.

Glucose Health, Inc. (GLUC) Stock Research Links

GLUC Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Rural Hospitals Face Shaky Future; Warbird RCM Steps In

Updated Category News Views 3

Revamping Revenue Cycle Management for Rural Healthcare In a world that's increasingly teetering on the delicate tightrope of balance sheets, Warbird Healthcare Advisors is stepping into the ring with fists up, ready to fight for rural hospitals. Introducing their latest venture, Warbird RCM Partners, they're honing in on revenue cycle management and billing services to...

Continue Reading
When Families Should Consider Life Insurance Plans

Updated Category News Views 4

Let’s talk about why life insurance isn’t just for those walking around with gray hair. K.D. the Insurance Queen from Centennial, Colorado, dishes out the clearest advice on when and why families ought to have it in their arsenal. A New Mindset on Life Insurance Some folks out there think life insurance is something you ponder in your twilight years. But here’s the...

Continue Reading
Critical Questions to Ask When Buying Life Insurance

Updated Category News Views 3

Getting Under the Hood of Life Insurance Alright, so you're thinking about life insurance. Not exactly a day at the beach, but it’s one of those crucial life things to nail down. Paula Miller, a savvy insurance pro, walks through what to consider before you just slap down a signature and hope for the best. The Basics: Policy Types and Coverage Life insurance can be as...

Continue Reading
Centrus Energy to Discuss Q3 Earnings on Nov 5 Call

Updated Category News Views 7

Centrus Energy Prepares for Earnings Call You ever feel that twinge in your gut right before a big disclosure? Well, that's where Centrus Energy’s about to take us as they gear up for their quarterly earnings call. On November 5th, bright and early at 8:30 a.m. Eastern Time, NYSE:LEU will be in the spotlight, laying out its Q3 results for all us nose-to-the-grindstone...

Continue Reading
Ellington's Q3 Earnings Call: What Investors Need to Know

Updated Category News Views 5

An Anticipated Unveiling Ellington Financial Inc. (NYSE:EFC) is gearing up to spill the beans on its third-quarter financials for 2026. It's all going down after the markets close on November 4th. I can tell you, folks, anyone keeping an eye on EFC will be itching to know what's inside those numbers. With a company this deep into financial assets, reading between the...

Continue Reading
Podium Surges Past $150M in AI ARR Milestone

Updated Category News Views 8

A New Era for Podium When the brass at Podium made a gamble on AI, they didn't just try squeezing it into their old business model. Oh no, they launched what feels like a startup within their existing empire—no half-measures, just full-throttle ambition. Fast forward two and a half years, and they've racked up over $150 million in annual recurring revenue from these...

Continue Reading
Harbour BioMed's Batoclimab Injected Into Myasthenia Market

Updated Category News Views 5

China's Green Light for Batoclimab When a new drug approval hits, particularly in a crucial market like China, it's a big deal. Harbour BioMed's recent go-ahead from the National Medical Products Administration (NMPA) for their Batoclimab injection is no exception. This marks the first full clinical cycle completion of an anti-FcRn treatment for generalized myasthenia...

Continue Reading
Gillis Joins McGinnis Lochridge as COO Amid Firm's Milestone

Updated Category News Views 6

An Experienced Executor at the Helm Now, here's a story that rings of continuity meeting change. McGinnis Lochridge, a staple of the Texas legal scene since 1927, has tapped Charles Gillis to take charge as their Chief Operating Officer. You'd think they're gearing up to celebrate a hundred years by shaking things up internally. Why not bring in someone seasoned, I say?...

Continue Reading
Dott's Q3 2026: Micromobility Growth Soars High

Updated Category News Views 5

Riding the Wave of Profit in Micromobility Sometimes all you need is a quick jolt of genius to turn the wheels of fortune. Dott seems to have hit that sweet spot in Q3 of 2026. Deploying 45,000 new vehicles wasn’t just a logistical feat; it was a calculated bet that paid off handsomely, bolstering their business to soaring heights. Performance that Packs a Punch The Q3...

Continue Reading
NYC's Carriage Horse Ban: A New Era for Urban Welfare

Updated Category News Views 4

You've got to hand it to New York City—this isn't just another Tuesday twist. The City Council's decision to nix horse-drawn carriages is like throwing a wrench in an antique machine. It's a bold move in a concrete jungle that's constantly wearing new coats. Tradition vs. Welfare: The Crux For years, the idea of horses prancing down NYC streets seemed like a quaint nod...

Continue Reading

Top 5 Most Recently Viewed Articles

KBR Secures $85 Million Contract for Essential Airfield Supplies

Updated Category News Views 252

KBR Secures Major Contract for Airfield Repair Solutions KBR (NYSE: KBR) has proudly announced that it has clinched a firm fixed-price contract worth $85 million with the U.S. Air Force. This contract focuses on the procurement, design, and delivery of essential training aids along with airfield damage repair kits around the globe. This operational venture falls under the...

Continue Reading
Medianet Unveils Comprehensive Platform for Media Intelligence

Updated Category News Views 138

Medianet got ready to launch its innovative media intelligence platform back in 2024, aiming to integrate various media services into a single seamless experience. This isn't just some run-of-the-mill upgrade; this is the kind of game-changer that could rattle competitors who’ve grown too comfortable in their foreign-owned thrones. Game-Changer Alert: Medianet’s...

Continue Reading
Visa Set to Reveal Q1 2025 Financials on January 30

Updated Category News Views 174

Visa Set to Announce Fiscal Q1 2025 Financial Results Visa (NYSE: V) is preparing to unveil its financial results for the first quarter of fiscal 2025. This much-anticipated announcement will take place on January 30, 2025, following the market’s closure. As per tradition, the company will file the details with the Securities and Exchange Commission and will provide the...

Continue Reading
EHang's Upcoming Financial Results and Innovations in Air Mobility

Updated Category News Views 171

EHang Holdings Limited Set to Announce Financial Results GUANGZHOU, China — EHang Holdings Limited (Nasdaq: EH), renowned for its pioneering Urban Air Mobility (UAM) technology, is preparing to unveil its financial results for the second quarter. Conference Call Details The company's earnings announcement is scheduled for Tuesday, ahead of the U.S. market opening. This...

Continue Reading
Real Estate Sales Trends: What August's Data Revealed

Updated Category News Views 221

Understanding August's Existing-Home Sales Trends Recent reports indicate that existing-home sales in August showed a slight decline of 0.2% compared to July. This data highlights the evolving landscape of the real estate market. The National Association of REALTORS® (NAR) provided insights into the current conditions affecting homebuyers and sellers, including...

Continue Reading
ection End -->